I think focusing on investors or an exchange is missing the point. The main issue with this company is it cant grow revenue in its core product. Its been at it for years and achieved very little, moving exchanges is not going to change anything.
Does anyone really see a realistic pathway for this company to start generating >$100m in revenue.
- Forums
- ASX - By Stock
- GSW
- Ann: Scheme of arrangement - Reasons for Judgment
Ann: Scheme of arrangement - Reasons for Judgment, page-8
-
-
- There are more pages in this discussion • 15 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add GSW (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
LGP
LITTLE GREEN PHARMA LTD
Paul Long, Chief Executive Officer
Paul Long
Chief Executive Officer
SPONSORED BY The Market Online